| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.215 | 1.091 | 8.152 | 28.896 | 32.952 | 34.437 | 3.063 | 0 | 364 | 0 |
| Total Income - EUR | 1.215 | 1.092 | 8.152 | 28.896 | 32.952 | 34.437 | 3.063 | 0 | 364 | 0 |
| Total Expenses - EUR | 790 | 272 | 2.773 | 15.858 | 18.000 | 17.166 | 8.462 | 9.872 | 1.365 | 0 |
| Gross Profit/Loss - EUR | 425 | 820 | 5.379 | 13.037 | 14.952 | 17.271 | -5.399 | -9.872 | -1.001 | 0 |
| Net Profit/Loss - EUR | 389 | 787 | 5.208 | 12.748 | 14.622 | 16.942 | -5.480 | -9.872 | -1.001 | 0 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sanvocmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 19.893 | 13.655 | 8.105 | 2.146 | 110 | 0 | 0 |
| Current Assets | 463 | 1.283 | 6.440 | 11.938 | 28.449 | 46.141 | 40.352 | 33.898 | 31.477 | 31.301 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 263 | 259 | 491 | 482 | 473 | 464 | 465 | 466 | 465 | 462 |
| Cash | 200 | 1.024 | 5.949 | 11.456 | 27.977 | 45.678 | 39.887 | 33.432 | 31.013 | 30.840 |
| Shareholders Funds | 75 | 862 | 5.267 | 17.919 | 32.194 | 48.526 | 41.969 | 32.228 | 31.129 | 30.955 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 388 | 422 | 1.173 | 13.912 | 9.911 | 5.721 | 529 | 1.780 | 349 | 347 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanvocmed Srl